Sleep disorders and neuromuscular diseases.
Culebras
Antonio
A
Department of Neurology, Upstate Medical University, Syracuse, NY, USA.
Kelly
John J
JJ
D000279:Administration, Cutaneous; D001930:Brain Injuries / Q000209:etiology; D045422:Continuous Positive Airway Pressure / Q000009:adverse effects; D003300:Copper / Q000172:deficiency; D003929:Diabetic Neuropathies / Q000473:pathology; D018491:Dopamine Agonists / Q000008:administration & dosage; D006801:Humans; D002546:Ischemic Attack, Transient / Q000150:complications; D009157:Myasthenia Gravis / Q000145:classification / Q000188:drug therapy; D009468:Neuromuscular Diseases / Q000150:complications / Q000628:therapy; D010523:Peripheral Nervous System Diseases / Q000150:complications; D012148:Restless Legs Syndrome / Q000150:complications / Q000628:therapy; D012891:Sleep Apnea Syndromes / Q000150:complications / Q000628:therapy; D012893:Sleep Wake Disorders / Q000150:complications / Q000628:therapy; D020521:Stroke / Q000150:complications; D013764:Tetrahydronaphthalenes / Q000008:administration & dosage; D013876:Thiophenes / Q000008:administration & dosage
D018491:Dopamine Agonists; D013764:Tetrahydronaphthalenes; D013876:Thiophenes; D003300:Copper; C047508:rotigotine